Abstract—Molecular heterogeneity in seven human metastatic melanoma cells lines is revealed using a double immunofluorescent assay by flow cytometry. It is evaluated that quite a small population of cells (up to 10%) expressed only vimentin, the main marker of melanoma. Only epithelial cytokeratins expression is revealed in a significantly greater number of cells (from 25 to 50%). The dominant molecular phenotype (50–80% cells expressed both markers), the coexpression of vimentin and cytokeratins, is identified for the first time. The authors assume that the latter phenotype of melanoma cells may be a molecular marker of the tumor’s aggressiveness and metastatic potential.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Trejdosiewicz, L.K., Southgate, J., Kemshead, J.T., and Hodges, G.M., Exp. Cell Res., 1986, vol. 164, no. 2, p. 388.
Banerjee, S.S. and Harris, M., Histopathology, 2000, vol. 36, no. 5, p. 387.
Korabiowska, M., Fischer, G., Steinacker, A., Stachura, J., Cordon-Cardo, C., and Brinck, U., Anticancer Res., 2004, vol. 24, no. 5B, p. 3203.
Hendrix, M.J.C., Seftor, E.A., Chu, Y.W., Seftor, R.E.B., Nagle, R.B., McDaniel, K., Leong, S.P.L., Yohem, K.H., Leibovitz, A.M., Meyskens, F.L., Conaway, D., Jr., Welch, D.R., Liotta, L.A., and Stetler-Stevenson, W., J. Natl. Cancer Inst., 1992, vol. 5, no. 84, p. 165. https://doi.org/10.1093/jnci/84.3.165
Kenda Suster, N., Smrkolj, S., and Virant-Klun, I., J. Ovarian Res., 2017, vol. 10, no. 1, p. 11. https://doi.org/10.1186/s13048-017-0306-7
Davidson, B., Holth, A., Hellesylt, E., Tan, T.Z., Huang, R.Y., Tropé, C., Nesland, J.M., and Thiery, J.P., Hum. Pathol., 2015, vol. 46, no. 1, p. 1. https://doi.org/10.1016/j.humpath.2014.10.004
Wu, D.I., Liu, L., Ren, C., Kong, D., Zhang, P., Jin, X., Wang, T., and Zhang, G., Oncol. Lett., 2016, vol. 11, no. 2, p. 1463. https://doi.org/10.3892/ol.2016.4092
Fuchs, U., Kivelä, T., Summanen, P., Immonen, I., and Tarkkanen, A., Am. J. Pathol., 1992, vol. 141, no. 1, p. 169.
Bogush, T.A., Aref’eva, A.A., Kalyuzhnyi, S.A., Bogush, E.A., Tyulyandin, S.A., Polotskii, B.E., and Davydov, M.M., Ross. Bioter. Zh., 2017, vol. 16, no. 4, p. 29. https://doi.org/10.17650/1726-9784-2017-16-4-29-33
Bogush, T.A., Kaliuzhny, S.A., Dudko, E.A., Kirsanov, V.Yu., Tjulandina, A.S., Bogush, E.A., Tjulandin, S.A., and Davydov, M.I., Moscow Univ. Chem. Bull. (Engl. Transl.), 2016, vol. 71, nos. 5–6, p. 307. https://doi.org/10.3103/S0027131416050035
Funding
This study was performed as part of the research program planned at the Blokhin Russian Cancer Research Center (research subject: Markers of Human Melanoma Stem Cells, registration no. AAAA-A16-116122210048-6).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
Additional information
Translated by M. Novikova
About this article
Cite this article
Bogush, T.A., Kaliuzhny, S.A., Basharina, A.A. et al. Coexpression of Vimentin and Cytokeratins in Human Melanoma Cell Lines. Moscow Univ. Chem. Bull. 74, 296–299 (2019). https://doi.org/10.3103/S0027131419060075
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3103/S0027131419060075